Home
About
Management
Board of Directors
Scientific Advisors
Programs
Pipeline Chart
About RNAi
About Obesity
Technology
Nucleic Acid Delivery
RNAi
Homing Peptides
Publications
News
Press Releases
Webcasts
Presentations
Arrowhead in the News
Investor Relations
Stock Information
SEC Filings
Corporate Governance
Presentations and Events
FAQ
Contact Investor Relations
Careers
Contact
About
Corporate Profile
Nanotechnology
Management
Christopher Anzalone, Ph.D.
President and CEO
Ken Myszkowski
Chief Financial Officer
Bruce Given, M.D.
Chief Operating Officer
Brendan P. Rae, Ph.D., J.D.
Chief Business Officer
Thomas Haag
Chief Patent Officer
Jane Davidson
Vice President, Administration
Corporate Profile
Download Corporate Profile ( PDF )